What a treatment is, who regulates it, and what to ask. 222 articles, newest first.
An upper lip lift shortens the skin distance between nose and lip, changing vermilion and tooth show through tissue excision and a permanent scar. Filler adds temporary volume and shape; it cannot remove philtral skin. The comparison begins with the anatomical job, not desired “fullness.”
A 1726-nm acne-laser clearance belongs to the named prescription device and stated inflammatory-acne indication. It does not authorize every platform, promise permanent clearing, treat acne scars, or prove superiority to medicine. Verify the model, 510(k), protocol, endpoint, evidence window, operator, and follow-up.
Alexandrite, diode, and long-pulsed Nd:YAG are laser families, not fixed rankings. Wavelength affects melanin absorption and penetration, while treatment also depends on platform, pulse, fluence, spot, cooling, skin response, hair target, area, operator, and schedule. Compare the complete settings strategy.
Two bounded 2026 filler approvals now exist: SKINVIVE by JUVÉDERM for specified injection to reduce neck lines in adults over 21, and RADIESSE diluted 1:2 with sterile saline for subdermal correction of décolleté wrinkles in patients 22 and older. They do not cover every filler, dilution, area, technique, or provider.
A BBL uses harvested fat through liposuction and subcutaneous grafting; buttock implant surgery places a manufactured device in a planned pocket. Compare donor-fat needs, incisions, device records, Florida rules, surveillance, complications, revision options, and the full safety system—not projection alone.
An authorized noninvasive body-contouring device may target local circumference, a fat bulge, muscle tone, or cellulite appearance; FDA says contouring does not treat obesity or cause weight loss. A weight-loss or weight-management device has its own indication, population, mechanism, evidence, and follow-up.
Botulinum toxin and dermal filler solve different appearance problems. A useful consultation starts by watching what changes at rest and in motion, naming whether the goal is less muscle pull or more contour, and checking the exact product, site, label, risks, and follow-up plan.
Recovery boots, condition-specific medical pumps, and perioperative compression systems may all inflate around a limb, but they are not interchangeable. Compare the exact device, FDA record, intended use, sleeve, pressure sequence, screening, protocol, monitoring, outcome, and responsible clinician.
A blunt cannula can change entry points, tissue passage, bruising, and some observed vascular-risk estimates, but it cannot eliminate intravascular injection. A needle can offer direct placement in selected planes. Compare anatomy, product, depth, technique, volume, visualization, injector, and emergency plan.
Weight loss during GLP-1 treatment can include measured lean-mass loss, but DXA lean mass is not identical to skeletal muscle, strength, or function. A useful program names the product, time point, measurement method, compartments, functional measures, trend, and interpreting clinician.
Finasteride 1 mg has a U.S. FDA-approved male-pattern-hair-loss indication; dutasteride products are approved for benign prostatic hyperplasia, so hair-loss use is off label. Oral, compounded topical, and combination offers need separate product, evidence, exposure, and safety records.
Enclomiphene, clomiphene, and testosterone are different product paths. The U.S. has no FDA-approved finished enclomiphene drug; clomiphene's approval is for a female ovulatory indication and male use is off label; testosterone products have product-specific approvals and labels.
An eyebrow transplant relocates living follicles that keep growing hair; microblading deposits pigment into skin to create hair-like marks. Compare the desired endpoint, donor hair and grooming, pigment and fading, scars, Florida artist or clinical records, maintenance, reversibility limits, and correction plan.
An FDA-approved intravenous ascorbic-acid product has a narrow labeled use for short-term treatment of scurvy when oral administration is not possible, insufficient, or contraindicated. That approval does not establish IV vitamin C as an FDA-approved wellness, immunity, anti-aging, fatigue, or cancer treatment.
A tummy tuck primarily reshapes the front of the abdomen; a lower body or belt lift extends skin excision around the trunk and may affect the waist, buttocks, and outer thighs. Compare the exact incision and region map, wall work, staging, risk, recovery support, and quote—not the package name.
Metformin is FDA approved for product-specific diabetes uses, not as an anti-aging or longevity drug. Animal experiments, mechanisms, biomarkers, and observational associations can motivate trials, but none alone proves that metformin extends healthy human lifespan outside an established clinical indication.
Mini and full facelift are not standardized procedure grades. Compare two plans by the exact face and neck regions treated, incision and dissection map, tissue layers moved, adjuncts, anesthesia, facility, scar and recovery plan, and what each operation intentionally leaves unchanged.
Foundayo (orforglipron) and Wegovy tablets (semaglutide) are FDA-approved oral weight-management drugs, but they are different molecules with different labels, administration instructions, dose systems, evidence, contraindications, and continuity plans. Compare the exact finished products, not the phrase “GLP-1 pill.”
Piezoelectric rhinoplasty uses an ultrasonic tool for bone work; conventional techniques use osteotomes and rasps. The tool may affect precision and early recovery measures, but it does not define the operation or guarantee long-term shape or airway. Compare the bone plan, access, evidence, surgeon, and endpoints.
“P-shot” is a marketing label, not one standardized, FDA-approved erectile-dysfunction treatment. Verify the diagnosis and responsible urology care, blood collection and PRP preparation, injection protocol, comparator, endpoints, evidence limits, adverse-event plan, and every device or approval claim.
Primary rhinoplasty operates on a nose without prior rhinoplasty; revision rhinoplasty must account for altered cartilage, bone, skin-soft-tissue envelope, scar, blood supply, airway, grafts, implants, and expectations from one or more earlier operations. The word “revision” does not identify the actual reconstruction.
Smooth and textured describe an implant's shell surface, not fill, shape, size, profile, or pocket. FDA says BIA-ALCL risk is higher with textured implants than smooth implants. Verify the exact model, current availability, labeling, device history, placement, surveillance, and revision plan.
Thigh liposuction removes selected fat but does not excise redundant skin. A thigh lift removes and repositions skin, may include fat treatment, and creates a longer scar. Compare skin quality, fat, inner versus outer thigh, scar tolerance, stability, and recovery support.
A transconjunctival lower blepharoplasty reaches the fat compartments from inside the eyelid; a transcutaneous approach uses an external incision near the lash line and can directly address skin and muscle. Neither label defines the fat plan, lid support, skin treatment, scar, adjuncts, or risk by itself.
Upper-arm liposuction reduces selected subcutaneous fat; an arm lift removes loose skin and may include fat removal. The meaningful tradeoff is residual laxity versus a longer permanent scar, with weight stability, tissue quality, movement, and recovery in the same record.
Fat transfer moves harvested fat into the breast; implants add a manufactured device with defined dimensions. The meaningful comparison is not natural versus artificial—it is desired volume, donor tissue, graft retention, imaging changes, implant surveillance, scars, and the likelihood of staged or future surgery.
Inframammary, periareolar, and transaxillary incisions reach the implant pocket from different directions. Scar location is only one tradeoff: exposure, tissue crossed, sensation, lactation evidence, device constraints, pocket control, and future re-entry also belong in the plan.
Implant volume in cubic centimeters does not determine base width, projection, height, or the final breast shape by itself. Profile is a product-line label, cup size is not a standardized surgical unit, and the choice has to fit measured breast and chest dimensions.
Over-muscle, under-muscle, subfascial, and dual-plane placements change tissue coverage, animation, dissection, and revision options. No pocket is universally best; the choice must fit implant dimensions, breast tissue, activity, skin, chest anatomy, and the exact operation.
A breast reduction removes meaningful breast volume and weight; a breast lift reshapes and repositions the existing breast envelope with little size reduction as its primary job. A reduction usually includes lifting steps, but a lift is not automatically a reduction.
Capsular contracture is tightening of scar tissue around a breast implant that may cause firmness, pain, displacement, or visible distortion. Baker grades are a shorthand, not a complete diagnosis; evaluation should document symptoms, implant condition, anatomy, and other causes before a revision is chosen.
Deep-plane and SMAS facelift labels describe different ways of releasing, repositioning, and securing facial tissues, but neither name is a standardized outcome grade. Current reviews do not justify a universal claim that one is safer, more natural, or longer-lasting for every face.
Breast implants are not lifetime devices, but ten years is not an automatic replacement deadline. Reoperation should follow the exact implant, symptoms, imaging when indicated, examination findings, preferences, and current labeling—not a calendar alone.
A drainless tummy tuck usually substitutes progressive-tension or quilting sutures for routine external drains; it is not simply the same operation with the tubes omitted. Both approaches can be reasonable, and neither guarantees freedom from seroma, aspiration, infection, or an unplanned drain.
A medication program and a metabolic or bariatric operation are not interchangeable doses of the same intervention. They use different eligibility frameworks, treatment exposures, endpoints, monitoring plans, risk windows, and long-term follow-up systems.
Liposuction removes accessible fat; excision directly removes firm gland or other tissue and can address skin or the nipple-areola complex. Many operations combine them. Before technique, confirm what tissue is present and whether a medical cause or suspicious finding needs its own evaluation.
Infrared and traditional saunas can both create heat stress, but they deliver it differently. A useful comparison measures the actual cabin conditions, thermal dose, study endpoint, device controls, and operating record—not the modality name alone.
FDA-approved ketamine injection is an anesthetic; psychiatric ketamine infusions are off-label. Spravato is FDA-approved esketamine nasal spray with indication-specific labeling and a REMS. Compounded ketamine nasal or oral products are not FDA-approved and do not inherit Spravato's evidence or authorization.
Labiaplasty is surgery on external labial tissue. “Vaginal rejuvenation” is an imprecise marketing label that may refer to vaginal or vulvar energy devices, surgery, or symptom claims. They do not treat the same anatomy, and neither label establishes an indication or expected outcome.
Tumescent describes a wetting-solution approach; power, ultrasound, and laser describe assistance used around cannula-based fat removal. These terms can coexist in one operation. None is a standardized quality grade or proof of skin tightening, less risk, or a better result.
Neck liposuction removes accessible fat; a neck lift can address skin and platysma and may include deeper structural work. The right comparison depends on what creates the contour—not a universal age cutoff or the promise that one smaller procedure can do every job.
Open rhinoplasty adds a transcolumellar incision to internal incisions; closed rhinoplasty uses internal incisions. Access affects exposure and scar location, but current evidence does not establish one approach as the universal choice for appearance, breathing, recovery, or revision risk.
Photodynamic therapy is a photosensitizing drug plus a specified activation protocol, not simply blue or red light. FDA-approved combinations have exact actinic-keratosis indications. Acne use may be off-label, and a light-only facial is not PDT.
Both saline and silicone gel breast implants have silicone shells, and neither is a lifetime device. Their fill behavior changes sizing workflow, feel, rippling and tissue-coverage questions, incision choices, rupture recognition, follow-up, and product-specific labeling.
Septoplasty primarily works on the internal septum; rhinoplasty reshapes nasal structure and may have aesthetic, functional, or combined goals; septorhinoplasty names a combined plan. The operative label should follow a documented airway-and-form exam, not replace it.
Focused low-intensity extracorporeal shockwave and radial pressure-wave devices create different energy fields; “acoustic wave” may describe either in marketing. For ED, verify the exact generator, protocol, study match, device status, clinician evaluation, and investigational boundary.
Classify a postoperative scar by age and feature before choosing care. Silicone can support prevention or raised-scar care after closure; injections target selected raised scars; lasers address defined color, thickness, texture, or mobility goals; revision changes the scar but starts a new healing cycle.
Therapeutic plasma exchange removes plasma and returns blood cells with replacement fluid; young-plasma infusion adds donor plasma. They are not the same intervention. Biomarker or epigenetic-clock changes in small studies do not establish slower aging, better function, or longer life.
